Parithera
Integrated solution combining Circulating Tumor Cells (CTC) enrichment and sequencing sample preparation in a single device
Parithera has raised €97k across 1 funding round from 1 investor, most recently a Debt round in Mar 2022. Based in Épalinges, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Épalinges, Switzerlandwww.parithera.com ↗
Total raised
€97k
€97,324
Funding rounds
1
Investors
1
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearParithera — funding by year — interactive chart.
Data table
| Parithera — funding by year | |
|---|---|
| 2022 | €97k |
Signals
High confidenceRaise-next likelihood8
base rate 45% for Debt
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-22 | Debt | €97k | Foundation for Technological Innovation (FIT) | View deal → |
Related news
- CHF 100’000 for Parithera ExTrace Dx Cancer Trackingstartupticker.ch · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData